Cidara Therapeutics, Inc.
CDTX
$66.96
$2.834.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 203.64% | -11.42% | 49.02% | -22.50% | 466.44% |
| Total Receivables | 9.74% | 0.00% | -0.29% | -27.67% | -67.74% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.80% | -1.56% | -53.53% | 1,380.53% | -42.74% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -0.02% | -0.20% | -- | -- | -- |
| Total Current Assets | 181.60% | -10.39% | 34.42% | -7.01% | 259.97% |
|
|
|||||
| Total Current Assets | 181.60% | -10.39% | 34.42% | -7.01% | 259.97% |
| Net Property, Plant & Equipment | -12.29% | -29.78% | -8.22% | -7.44% | -4.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.04% | 0.00% | -92.27% | 1,094.23% | -89.46% |
| Total Assets | 178.69% | -10.74% | 32.32% | -6.36% | 228.85% |
|
|
|||||
| Total Accounts Payable | -54.95% | 35.73% | 21.60% | 29.68% | -54.74% |
| Total Accrued Expenses | -32.63% | -4.13% | 11.34% | 11.08% | 3.59% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.18% | -12.48% | 3.86% | 3.88% | 3.96% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -99.95% |
| Total Other Current Liabilities | -- | -- | -- | -- | -99.95% |
| Total Current Liabilities | -33.79% | -1.50% | 11.76% | 11.85% | -39.41% |
|
|
|||||
| Total Current Liabilities | -33.79% | -1.50% | 11.76% | 11.85% | -39.41% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -32.36% | -36.09% | -18.12% | -14.97% | -12.72% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -33.75% | -2.80% | 10.25% | 10.09% | -39.82% |
|
|
|||||
| Common Stock & APIC | 49.61% | 0.24% | 14.82% | 0.10% | 55.29% |
| Retained Earnings | -4.05% | -3.84% | -9.36% | -2.94% | -20.19% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 253.73% | -13.24% | 41.23% | -11.69% | 836.42% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 253.73% | -13.24% | 41.23% | -11.69% | 836.42% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 253.73% | -13.24% | 41.23% | -11.69% | 836.42% |
|
|
|||||